Combination Products
Global pathway comparison without false equivalence
How to compare the United States, European Union, and Japan while preserving jurisdiction-specific logic.
A global comparison should not flatten different regulatory systems into one generic checklist. It should show where concepts align, where authority structures differ, and which evidence can be reused with adaptation.
Anchor the product profile
Use one controlled description of intended use, constituents, mode of action, users, presentation, manufacturing, and claims. Differences in this baseline can create artificial pathway differences.
Compare across consistent dimensions
Examine authority jurisdiction, classification, consultation mechanisms, quality requirements, evidence expectations, submission structure, review sequence, post-market obligations, and change pathways.
Label uncertainty
Distinguish confirmed requirements from interpretations, assumptions, and questions requiring authority engagement.
Further regulatory context
Read medical device regulatory definitions and authoritative references. Explore the workflows eeRegOS supports.
Editorial note: This content is educational and does not constitute legal or regulatory advice. Product-specific decisions should be reviewed by qualified professionals using current authoritative sources.
